Hacon Pharmaceutical Co., Ltd

Zhejiang Hacon Pharmaceutical Co., Ltd. is the one of the first key high-tech enterprise in Zhejiang. The company is located in the "new-drug-valley" in Hangzhou economic and technological development area and it covers an area of 53000 square meters. It’s mainly engaged in research, development, production and sales of Chinese and Western medicines and marine biological drugs . The company has many advanced production lines like freeze-dried powder, capsule, tablets, granules, liquid and they were all passed the GMP certification of the 2010 edition.

Company's existing drug approval number is more than 30, involves in multiple areas such as neurological drugs, hemostatic drugs, anti-infectious drugs. Among them, the “Reinhardt sea cumber capsule” of Xi Enkai brand is the key product of the company which is the first marine nootropic drug and a variety of exclusive Chinese medicine protection, it also won the new national key product. At the same time, it was included in the national high-tech industrialization demonstration project. Other products such as thrombin, tinisazole gargle, gluconic acid zinc sugar granules were all included in the national health insurance directory and have high visibility and recognition among the domestic similar products.

Assets reorganization of the company was happened at the end of 2008. With the support of the new controlling shareholders, the company increased investment to new product development, continuously improved the enterprise’s management level and market competitiveness, be committed to become a domestic high-end brand of Chinese medicine for chronic diseases of elderly people and the vanguard of marine organism medicine.We are committed to make our own contribution to the motherland development of pharmaceutical industry and the health of the people's life.

  • In January 1992, the predecessor of Hangzhou Conba bio engineering company.
  • In December 1994, the formation of the establishment of Hangzhou Kang biological pharmaceutical Co., ltd..
  • 2005, the change for the Zhejiang Hang Kang Marine Biological Pharmaceutical Co., ltd..
  • In April 2008, changed to Zhejiang Hang Kang Pharmaceutical Co., Ltd.; the same year in September, Shanghai Noel Biological Pharmaceutical Co., Ltd. became the new controlling shareholder.
  • July 2010, the company registered capital increased to 54500000 yuan.
  • April 2013, the company registered capital increased to 80000000 yuan.